RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications
A post-authorisation safety study in the CPRD
Plana Hortoneda, E., Rivero Ferrer, M. E., Aguado, J., Saigi-Morgui, N., Nuevo, J., Daoud, SZ., Lei, A., Perez-Gutthann, S., & Rebordosa Garcia, C. (2019). Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications: A post-authorisation safety study in the CPRD. Pharmacoepidemiology and Drug Safety, 28(Suppl 2), 1153. https://doi.org/10.1002/pds.4864
